Skip to main content

Clinical Trials

Institute of Human Virology
Vaccine Research Trial

Preventive HIV Vaccine (FLSC) in Healthy Volunteers Without HIV Infection

This is a Phase 1 randomized, placebo-controlled, modified double-blinded clinical trial designed to evaluate the safety and immunogenicity of a HIV vaccine called FLSC (full length single chain) in healthy volunteers without HIV infection. This novel vaccine was developed by investigators at the Institute of Human Virology as a strategy to help prevent HIV infection. Volunteers must be healthy, 18-45 years of age, HIV negative, and have never previously participated in an HIV or DNA vaccine trial. Compensation given for travel and expenses.

Contact: Amy Nelson, RN (410) 706-1684

Clinical trials are studies designed to find new and better ways to treat patients. Through clinical trials, scientists and physicians at the Institute of Human Virology have broken new ground in the development of treatments.

Why Enroll in a Clinical Trial?

  • Clinical trials test new treatments for HIV
  • During the trial you will be closely monitored by health care professionals and doctors.
  • You will receive compensation for your time and effort.
  • Your participation can be a valuable contribution to future research and treatment of people with HIV

IHV Clinical Trials Unit

Institute of Human Virology
725 w. Lombard St.
Baltimore, Md. 21201

To enroll in a study call 410-706-0100 or toll free 1-866-448-4448.

Division Head

Robert Redfield, MD
Associate Director and Professor